SCHEMBL10349232

SCHEMBL10349232

CC=C(C)Oc1ccc(Cl)c2c1CCN(C)CC2

nearest known ligand 0.61

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 5/20 0.61
ADRA2B P18089 5/20 0.61
ADRA2C P18825 5/20 0.61
ADRA1D P25100 4/20 0.61
ADRA1A P35348 4/20 0.61
ADRA1B P35368 4/20 0.61
CYP2D6 P10635 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9548521 0.84 ADRA2A (0.59) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL8910106 0.82 ADRA2A (0.57) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL10349370 0.79 ADRA2A (0.65) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL9421158 0.78 ADRA2A (0.58) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL9421156 0.78 ADRA2A (0.58) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL10349369 0.77 ADRA2A (0.58) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL8091302 0.76 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL29389267 0.76 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL8910175 0.76 ADRA2A (0.48) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL9548515 0.75 ADRA2A (0.56) ADRA2AADRA2BADRA2CADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0238281-B1 SELECTIVE ALPHA-ADRENERGIC RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1990-05-16 EP disclosed
EP-0238281-A1 Selective alpha-adrenergic receptor antagonists SMITHKLINE BEECHAM CORPORATION (US) 1987-09-23 EP disclosed
US-4683229-A HYPOTENSIVE AGENTS SMITHKLINE BECKMAN CORPORATION (US) 1987-07-28 US disclosed